1	Decreased	decrease	_	_	_	_	_	_	_
2	concentration	concentration	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	1,25-dihydroxyvitamin	1,25-dihydroxyvitamin	_	_	_	_	_	_	_
5	D3	d3	_	_	_	_	_	_	_
6	receptors	receptor	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	peripheral	peripheral	_	_	_	_	_	_	_
9	mononuclear	mononuclear	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	patients	patient	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	X-linked	x-linked	_	_	_	_	_	_	_
15	hypophosphatemic	hypophosphatemic	_	_	_	_	_	_	_
16	rickets	ricket	_	_	_	_	_	_	_
17	:	:	_	_	_	_	_	_	_
18	effect	effect	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	phosphate	phosphate	_	_	_	_	_	_	_
21	supplementation	supplementation	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Abnormal	abnormal	_	_	_	_	_	_	_
2	renal	renal	_	_	_	_	_	_	_
3	tubular	tubular	_	_	_	_	_	_	_
4	phosphate	phosphate	_	_	_	_	_	_	_
5	transport	transport	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	considered	consider	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	be	be	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	primary	primary	_	_	_	_	_	_	_
12	defect	defect	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	X-linked	x-linked	_	_	_	_	_	_	_
15	hypophosphatemic	hypophosphatemic	_	_	_	_	_	_	_
16	rickets	ricket	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	XLH	XLH	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	resistance	resistance	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	vitamin	vitamin	_	_	_	_	_	_	_
7	D	D	_	_	_	_	_	_	_
8	treatment	treatment	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	XLH	XLH	_	_	_	_	_	_	_
11	cannot	cannot	_	_	_	_	_	_	_
12	be	be	_	_	_	_	_	_	_
13	explained	explain	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	hypophosphatemia	hypophosphatemia	_	_	_	_	_	_	_
16	alone	alone	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	most	most	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	actions	action	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	vitamin	vitamin	_	_	_	_	_	_	_
8	D	D	_	_	_	_	_	_	_
9	are	be	_	_	_	_	_	_	_
10	mediated	mediate	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	its	its	_	_	_	_	_	_	_
13	receptors	receptor	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	VDR	VDR	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	abnormalities	abnormality	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	VDR	VDR	_	_	_	_	_	_	_
21	have	have	_	_	_	_	_	_	_
22	been	be	_	_	_	_	_	_	_
23	postulated	postulate	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	XLH	XLH	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	order	order	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	investigate	investigate	_	_	_	_	_	_	_
5	this	this	_	_	_	_	_	_	_
6	possibility	possibility	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	we	we	_	_	_	_	_	_	_
9	measured	measure	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	concentration	concentration	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	VDR	VDR	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	PHA-activated	pha-activated	_	_	_	_	_	_	_
16	peripheral	peripheral	_	_	_	_	_	_	_
17	mononuclear	mononuclear	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	from	from	_	_	_	_	_	_	_
20	10	10	_	_	_	_	_	_	_
21	XLH	XLH	_	_	_	_	_	_	_
22	patients	patient	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Patients	patient	_	_	_	_	_	_	_
2	without	without	_	_	_	_	_	_	_
3	phosphate	phosphate	_	_	_	_	_	_	_
4	supplementation	supplementation	_	_	_	_	_	_	_
5	showed	show	_	_	_	_	_	_	_
6	significantly	significantly	_	_	_	_	_	_	_
7	lower	low	_	_	_	_	_	_	_
8	concentration	concentration	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	21.7	21.7	_	_	_	_	_	_	_
11	+/-	+/-	_	_	_	_	_	_	_
12	5.1	5.1	_	_	_	_	_	_	_
13	fmol/mg	fmol/mg	_	_	_	_	_	_	_
14	protein	protein	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	mean	mean	_	_	_	_	_	_	_
17	+/-	+/-	_	_	_	_	_	_	_
18	SEM	sem	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	compared	compare	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	normal	normal	_	_	_	_	_	_	_
24	controls	control	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	60.7	60.7	_	_	_	_	_	_	_
27	+/-	+/-	_	_	_	_	_	_	_
28	4.0	4.0	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	On	on	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	contrary	contrary	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	there	there	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	no	no	_	_	_	_	_	_	_
8	significant	significant	_	_	_	_	_	_	_
9	difference	difference	_	_	_	_	_	_	_
10	between	between	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	phosphate-supplemented	phosphate-supplemented	_	_	_	_	_	_	_
13	patients	patient	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	58.3	58.3	_	_	_	_	_	_	_
16	+/-	+/-	_	_	_	_	_	_	_
17	2.7	2.7	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	controls	control	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	There	there	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	significant	significant	_	_	_	_	_	_	_
5	positive	positive	_	_	_	_	_	_	_
6	correlation	correlation	_	_	_	_	_	_	_
7	between	between	_	_	_	_	_	_	_
8	VDR	VDR	_	_	_	_	_	_	_
9	concentration	concentration	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	serum	serum	_	_	_	_	_	_	_
12	phosphate	phosphate	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	P	p	_	_	_	_	_	_	_
15	less	less	_	_	_	_	_	_	_
16	than	than	_	_	_	_	_	_	_
17	0.05	0.05	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	two	two	_	_	_	_	_	_	_
3	patients	patient	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	VDR	VDR	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	increased	increase	_	_	_	_	_	_	_
8	after	after	_	_	_	_	_	_	_
9	daily	daily	_	_	_	_	_	_	_
10	phosphate	phosphate	_	_	_	_	_	_	_
11	supplementation	supplementation	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	started	start	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	decreased	decrease	_	_	_	_	_	_	_
7	concentration	concentration	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	VDR	VDR	_	_	_	_	_	_	_
10	secondary	secondary	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	persistent	persistent	_	_	_	_	_	_	_
13	hypophosphatemia	hypophosphatemia	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	one	one	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	causes	cause	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	vitamin	vitamin	_	_	_	_	_	_	_
21	D	D	_	_	_	_	_	_	_
22	resistance	resistance	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	XLH	XLH	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

